Skin Guide · Periorbital Care
Dark Circles Under the Eyes: Causes and What Actually Helps
Dark circles under the eyes have four distinct causes: vascular (blood pooling visible through thin skin), pigmentary (excess melanin), structural (tear-trough shadows), and skin thinning. Most people have more than one type. Topical ingredients can genuinely help vascular and pigmentary types, with a 2024 clinical study showing significant improvement via caffeine, peptides, and vitamin C after 12 weeks.1 Structural darkness responds better to professional treatment.
Dark circles are one of the most-searched skin concerns, and also one of the most misunderstood. The frustrating part: they don't have a single cause. Treating the wrong type with the right ingredient still gets you nowhere. This guide maps the actual biology behind each type, then runs through the ingredients that have peer-reviewed evidence, honestly noting where that evidence is thin.
// What's in this guide
01What dark circles actually are
The skin under your lower eyelid is the thinnest on your entire face, typically 0.5 mm thick compared to 2 mm elsewhere. That thinness means whatever is underneath, blood vessels, pigment, muscle, fat, is closer to the surface and more visible. Dark circles are not one thing; they are a collective name for several distinct phenomena that can look identical from the outside and require entirely different approaches.
A 2009 review in Dermatologic Surgery laid the framework that most dermatologists still use: dark circles arise from excessive pigmentation, thin and translucent skin over the orbicularis oculi muscle, and shadowing from tear-trough hollowing.2 A 2021 systematic review in the same journal confirmed that in the majority of patients, multiple causes coexist, which is why no single-ingredient approach consistently clears them.3
Understanding which type or combination you're dealing with is more valuable than any ingredient list. The sections below give you the diagnostic map.
02The four root causes: a diagnostic map
Vascular: the most common type
Vascular dark circles appear bluish-purple, sometimes with a reddish tint, and are caused by blood pooling in the periorbital microvasculature combined with hemoglobin breakdown products. Because the overlying skin is so thin, the color of the underlying blood is visible. Pressing gently on the area and watching whether the color fades and returns gives a quick indication: if it blanches and comes back, the cause is primarily vascular.
Contributing factors include genetics (venous anatomy is inherited), fatigue, allergies (which drive histamine-related vessel dilation), and fluid retention. A 2024 study in the Journal of Cosmetic Dermatology used Laser Doppler flowmetry and Chromameter measurements to confirm that microvasculature congestion and hemoglobin degradation products are the dominant objective driver in the majority of subjects with dark circles.1
Bluish or purplish hue, worse in the morning, tends to run in families, worsens with allergies or sleep deprivation. Pressing gently causes temporary blanching.
Pigmentary: excess melanin
Pigmentary dark circles are brown or gray-brown in tone and result from excess melanin deposited in the periorbital skin. This type is more common in people with Fitzpatrick phototypes III through VI, but it occurs across all skin tones. Contributing factors include chronic sun exposure (UV triggers melanogenesis), post-inflammatory hyperpigmentation from rubbing or eczema, and baseline genetic melanocyte activity in the periorbital zone.
This type responds best to tyrosinase-inhibiting ingredients applied consistently. The pigment sits in the epidermis and, in some cases, the upper dermis, meaning topicals can reach it if formulated at the right concentration and pH. The evidence base for treating periorbital pigmentation largely overlaps with the broader evidence for facial hyperpigmentation, since the underlying biology is the same.
Brown or warm gray tone, does not blanch with pressure, worsens with sun exposure and inflammation, may improve with consistent use of tyrosinase inhibitors over 8-12 weeks.
Structural: the shadow problem
Structural dark circles are not really about color at all; they are shadows. The tear trough is a ligament-anchored groove that runs from the inner corner of the eye downward along the cheek. When the fat pad beneath the lower eyelid thins with age, or when the overlying skin loses collagen and volume, this groove deepens and casts a shadow that looks dark regardless of melanin or vascular status.
This type does not respond meaningfully to topical pigment-correcting ingredients, because there is no pigment to correct. Ingredients that support periorbital collagen and skin firmness, such as peptides or retinoids used carefully, may slow the progression of structural dark circles by supporting the skin scaffold over time. However, the 2021 systematic review notes that fillers and autologous fat grafting are the most effective interventions for tear-trough hollowing.3
Thin skin: the translucency factor
Some people simply have naturally thin periorbital skin that makes any underlying structure more visible. This can be genetic or develop with age as collagen production slows and skin thins. Ingredients that support the skin barrier and collagen synthesis are the most relevant here, not brighteners. Retinoids, peptides, and niacinamide all have supporting roles, though clinical trials specifically measuring periorbital skin thickness in response to topicals are limited.
03Sleep, lifestyle, and the factors you can control
Dark circles are strongly associated with poor sleep in the public imagination, and the association is real but partial. Sleep deprivation reduces periorbital microcirculation, increases puffiness from fluid retention (which deepens shadows), and elevates cortisol, which over time promotes inflammatory pigmentation. None of this means sleep is the primary driver for everyone, but for vascular-dominant dark circles, sleep quality is a genuinely addressable variable.
A 2024 Mendelian randomization study using UK Biobank data found that coffee intake, which carries a significant caffeine load, was associated with increased skin aging risk (OR: 1.040), while tea intake showed a protective association for pigmentation (OR: 0.972).4 This is a population-level signal, not a prescription, but it is a reminder that systemic circulation and inflammation affect periorbital skin the same way they affect the rest of the face.
A few lifestyle factors with decent evidence for periorbital appearance:
- Sleep position: Sleeping flat allows fluid to pool around the eyes; a slight head elevation reduces morning puffiness for vascular types.
- Allergen management: Allergic rhinitis drives histamine-mediated vessel dilation under the eyes. Managing allergies often visibly reduces dark circles in people where this is the dominant trigger.
- Sun protection: Daily SPF is the single most effective way to prevent the gradual pigment accumulation that drives pigmentary dark circles over years. Mineral SPF under the eyes is better tolerated than chemical filters for most people.
- Rubbing: Habitual eye rubbing causes repeated low-grade trauma that drives post-inflammatory hyperpigmentation. This is particularly relevant in people with eczema or contact allergies.
Lifestyle optimization helps for vascular and allergy-driven dark circles. It won't move the needle on structural or genetic pigmentary types. If yours persist through every lifestyle change, that tells you something useful about the underlying cause.
04Topical ingredients with real evidence
The periorbital area is challenging for topicals: the skin is thin and therefore more sensitive to irritation, and the anatomy is different from the rest of the face. Some ingredients that work well for facial hyperpigmentation need to be used at lower concentrations under the eyes. Here is where the evidence sits for the most-studied actives.
Caffeine: vascular constriction and fluid drainage
Caffeine is the most common ingredient in eye creams, with a pharmacological rationale that holds up. Applied topically, it reaches the dermis rapidly: a 2008 study in the British Journal of Clinical Pharmacology showed caffeine was detectable in blood within 5 minutes when applied to skin with open follicles, versus 20 minutes when follicle pathways were blocked.5 Topically applied, caffeine acts as a vasoconstrictor and has known anti-edema properties, which directly addresses the puffiness and vascular pooling component of dark circles.
A 2024 multicorrective eye cream trial that included caffeine alongside vitamin C, peptides, and botanical extracts showed significant objective improvement in infraorbital dark circles over 12 weeks via Laser Doppler and Chromameter measurement, with the primary mechanism being reduction in microvasculature congestion and hemoglobin-related pigmentation.1 Worth noting: caffeine was one ingredient among several in that study, so attributing the results to caffeine alone would overstate the evidence. As a standalone, caffeine's periorbital benefits are well-supported mechanistically; large placebo-controlled trials on caffeine alone for dark circles remain limited.
Niacinamide: melanosome transfer inhibition
Niacinamide at 4-5% inhibits the transfer of melanosomes from melanocytes to surrounding keratinocytes, which reduces visible pigment over 8-12 weeks without inhibiting melanin synthesis itself. This mechanism means it does not cause the rebound hyperpigmentation sometimes seen with hydroquinone. It is also well-tolerated at the low concentrations needed for periorbital use and supports the skin barrier, which is a useful secondary benefit for thin under-eye skin.
A 12-week clinical serum study combining 5% niacinamide with 3% tranexamic acid and 1% kojic acid showed significant improvements in post-inflammatory hyperpigmentation and overall skin tone beginning at week 2 and continuing through week 12, across diverse skin tones.6 Niacinamide's individual contribution in combination products is harder to isolate, but the broader evidence base for facial hyperpigmentation is strong. Our deeper breakdown is in the niacinamide for hyperpigmentation guide.
Vitamin C: antioxidant and tyrosinase inhibition
L-ascorbic acid works on periorbital pigmentation through two routes: it inhibits tyrosinase (the enzyme that drives melanin synthesis) and it provides antioxidant defense against UV-driven melanogenesis. The periorbital challenge is that effective concentrations of L-ascorbic acid (10-20%) are formulated at low pH, which can cause stinging on thin under-eye skin. Gentler derivatives like ascorbyl glucoside or tetrahexyldecyl ascorbate are better tolerated around the eyes, though they carry modestly less evidence than the acid form.
Coffee-derived chlorogenic acid, a close polyphenol relative of ascorbic acid, has been shown to suppress UV-induced pigmentation in mouse models via MAPK/ERK1/2 pathway inhibition.7 The mechanism is relevant, though human periorbital data specifically for chlorogenic acid is not yet established.
Tyrosinase inhibitors: kojic acid, alpha-arbutin, thiamidol
For more stubborn pigmentary dark circles, ingredients that directly inhibit tyrosinase have the strongest topical evidence. The landscape here is well-studied:
- Kojic acid: A fungal metabolite with reliable tyrosinase-inhibiting activity. A 12-week single-center study confirmed significant visible improvement in hyperpigmented spots using a formula containing kojic dipalmitate as one of several actives.8 The periorbital-specific evidence base is limited, but the mechanism applies directly to pigmentary dark circles.
- Alpha-arbutin: A reversible tyrosinase inhibitor derived from plants. A comparative study in Fitzpatrick phototype IV-V subjects found alpha-arbutin produced significant pigmentation reduction where several other actives, including azelaic acid 20%, did not.9
- Thiamidol: The highest-evidence OTC tyrosinase inhibitor currently available. A 2019 RCT found a 79% responder rate versus 61% for hydroquinone in a split-face trial with no adverse events on the thiamidol side.10 A 2021 study specifically on post-inflammatory hyperpigmentation found 100% of subjects reported visible reduction by week 12.11 The caveat: most thiamidol studies are industry-sponsored by the ingredient's manufacturer, and periorbital-specific trials are absent from the published literature.
Peptides: collagen support for the structural component
Peptides that signal collagen synthesis, such as palmitoyl pentapeptide-4 (Matrixyl) and copper peptides (Copper Tripeptide-1), support the thickening of periorbital skin over time, which reduces the translucency that makes vascular and structural darkness more visible. They do not address pigment directly, but for people whose dark circles are driven partly by thin skin, this matters. A full actives-based routine for the under-eye area typically includes both a pigment-targeting ingredient and a collagen-supporting one.
The 2024 multicorrective eye cream study that showed objective dark circle improvement included peptides alongside caffeine and vitamin C, and the measured outcome included improvements in skin firmness and visible vessel congestion simultaneously.1
Do peptides help the look of the under-eye area, and how do you apply them safely?
For dark circles driven partly by thin, translucent skin, copper peptides are worth including. By supporting the skin's own collagen signaling, they help the under-eye area look denser and less see-through over time, which softens how much the underlying vessels and shadows show through. This is an appearance benefit that builds over weeks rather than an overnight change, and it works best next to a pigment-targeting active rather than on its own.
Application matters more here than anywhere else on the face because the skin is delicate. Use a small amount, tap it in gently with your ring finger rather than rubbing, and stay on the orbital bone rather than going right up to the lash line. Keep the product away from the waterline and the inner corner so nothing migrates into the eye, and patch test first if your skin is reactive. If any product gets into the eye or causes stinging, rinse and stop. When in doubt around the eyes, choose formulas labelled ophthalmologist-tested and keep the application light.
05Dark-circle ingredient guide: what targets what
No single ingredient addresses all four types. The table below maps each ingredient to the dark-circle mechanism it actually targets, the evidence level, and relevant application notes for the periorbital area specifically.
| Ingredient | Dark-circle type targeted | Mechanism | Evidence level | Periorbital notes |
|---|---|---|---|---|
| Caffeine (topical) | Vascular, puffiness | Vasoconstriction, anti-edema, phosphodiesterase inhibition | Moderate: mechanistic + multicorrective RCT | Well-tolerated; onset within minutes for puffiness; combine with other actives for best results |
| Niacinamide 4-5% | Pigmentary | Inhibits melanosome transfer; supports barrier | Good: multiple RCTs for facial pigment; periorbital data limited | Excellent tolerability; start at 4%; safe to layer with most ingredients |
| Vitamin C (L-ascorbic acid) | Pigmentary, vascular oxidation | Tyrosinase inhibition; antioxidant; collagen cofactor | Good for facial pigment; periorbital irritation risk at higher % | Use stable derivative (ascorbyl glucoside, tetrahexyldecyl ascorbate) under eyes; 5-10% range |
| Alpha-arbutin 2-5% | Pigmentary | Reversible tyrosinase inhibitor; no rebound | Good: outperformed multiple actives in phototype IV-V study | Gentle enough for daily periorbital use; results at 8-12 weeks |
| Kojic acid 1-2% | Pigmentary | Tyrosinase inhibition + antioxidant | Moderate: multi-ingredient studies positive; solo periorbital data limited | Some irritation risk at higher concentrations; use in combination formulas |
| Thiamidol (isobutylamido thiazolyl resorcinol) | Pigmentary | Potent reversible tyrosinase inhibitor; 79% responder rate vs HQ | Strong for melasma/PIH; mostly industry-sponsored; periorbital-specific trials absent | Use 0.1-0.2%; excellent tolerability; maintenance required to prevent regression |
| Tranexamic acid 2-5% | Pigmentary | Inhibits UV-induced plasminogen activator; reduces melanocyte stimulation | Moderate: serum combination studies positive; solo periorbital trials limited | Well-tolerated; pairs well with niacinamide in combination serums |
| Collagen-stimulating peptides | Structural, thin skin | Signal fibroblast collagen synthesis; support ECM | Moderate: anti-aging RCTs; periorbital-specific outcomes less studied | Supports skin thickening over 8-12 weeks; reduces translucency over time |
| Retinoids (low-dose) | Pigmentary, thin skin | Cell turnover; collagen stimulation; mild tyrosinase inhibition | Good overall; periorbital use requires low concentration due to irritation risk | Use 0.025-0.05% retinol maximum under eyes; introduce slowly; always follow with SPF |
| SPF (daily broad-spectrum) | Pigmentary (prevention) | Blocks UV-triggered melanogenesis | Strong: prevents accumulation; best evidence is the absence of worsening | Mineral SPF tolerated best on thin periorbital skin; apply every morning regardless of cloud cover |
06How to build a periorbital routine
The periorbital area requires a lighter touch than the rest of the face. Layering too many actives in the same step causes irritation, and irritation causes post-inflammatory hyperpigmentation, the exact problem you are trying to fix. A minimal, consistent approach outperforms an ambitious one that gets abandoned after a week of stinging.
Morning: protection first
The most important step in any periorbital routine is daily SPF applied all the way to the orbital bone. UV exposure is the primary driver of long-term pigment accumulation, and no brightening ingredient can keep pace with unprotected sun exposure. A light mineral SPF formulated for the face (zinc oxide or titanium dioxide) is gentler under the eyes than most chemical filters.
If you use a caffeine-containing eye product, morning is the right time: it addresses the puffiness and vascular congestion that build overnight, and the vasoconstricting effect is most visible in the first hour after waking. Apply before moisturizer, using the ring finger to tap gently, no rubbing.
Evening: active ingredients
Evening is when actives targeting pigment do their work, since melanogenesis is not being constantly re-stimulated by UV. A niacinamide-containing moisturizer or serum applied to the under-eye area before sleep is a sensible baseline for anyone with pigmentary dark circles. For those with more persistent pigmentation, adding alpha-arbutin or tranexamic acid in a serum one to two steps earlier works well.
If you use a retinoid elsewhere in your routine, the under-eye area warrants a lower concentration and every-other-night frequency until tolerance is established. The skin here is simply too thin for the same dose you would use on your cheeks. Apply the retinoid to the rest of the face first, let it absorb, and then use a richer eye cream with peptides to seal the periorbital zone.
Vascular puffiness responds within days to caffeine-based products. Pigmentary dark circles take 8-12 weeks of consistent use before meaningful change is visible; this aligns with the melanocyte turnover cycle. Structural dark circles improve slowly with collagen-supporting ingredients, over months rather than weeks, and may not respond fully to topicals alone.
What to avoid
- Rubbing or pulling the skin: generates mechanical trauma that triggers post-inflammatory hyperpigmentation.
- High-dose retinoids without buffer: 0.5% retinol or above applied directly under the eyes without a moisturizer barrier tends to cause visible irritation and, eventually, more darkness.
- Fragrance: the periorbital skin is more permeable than the rest of the face and more prone to contact dermatitis. Fragrance-free formulations reduce this risk.
- Skipping SPF because it's cloudy: UVA penetrates clouds and is the main driver of chronic periorbital pigmentation.
07When topicals aren't enough
There are situations where topical skincare is genuinely the wrong tool, and using it anyway just delays the conversation that would actually help.
Structural dark circles from significant tear-trough volume loss respond best to hyaluronic acid fillers or autologous fat grafting. The 2021 systematic review in Dermatologic Surgery concluded that soft tissue fillers are among the most effective interventions for volume-loss-driven dark circles.3 These are clinical procedures requiring a qualified professional; this is not an area for at-home tools.
Deep pigmentation that has been present for years, especially in darker Fitzpatrick phototypes, may benefit from clinical-grade chemical peels or laser protocols alongside topical maintenance. The evidence for laser treatment of periorbital hyperpigmentation is mixed but generally positive for the right phototype and correct device selection, areas where dermatologist expertise matters more than in most skincare decisions.
For vascular-dominant dark circles with a strong genetic component, topicals and lifestyle can reduce but are unlikely to eliminate the underlying anatomy. This is worth knowing before investing heavily in products.
If dark circles appear suddenly, change in character, or are accompanied by other facial changes, a dermatology consultation is worth prioritizing over any skincare protocol. The MAXXING Skin Care collection supports a consistent topical routine, but it is not a substitute for clinical assessment.
08Frequently asked questions
Dark circles have four main causes: vascular (blood pooling and hemoglobin breakdown products visible through thin lower-eyelid skin), pigmentary (excess melanin from sun exposure, inflammation, or genetics), structural (the tear-trough hollow casting a shadow), and skin thinning. Most people have a combination. A 2009 review in Dermatologic Surgery confirmed that multiple causes coexist in the majority of patients, which is why single-ingredient approaches often underperform.
Yes, but it is one factor among many. Poor sleep reduces periorbital circulation, increases fluid retention and puffiness (which deepens shadows), and elevates cortisol, which promotes inflammatory pigmentation over time. Consistent sleep deprivation also impairs overnight skin repair. However, dark circles caused primarily by genetics, deep tear troughs, or chronic pigmentation will persist regardless of sleep quality.
Yes, for vascular and pigmentary types. A 2024 study in the Journal of Cosmetic Dermatology on a multicorrective eye cream with caffeine, vitamin C, peptides, and botanical extracts showed significant objective improvement in infraorbital dark circles over 12 weeks, mainly by reducing microvasculature congestion, melanin, and hemoglobin degradation products. Tyrosinase inhibitors like niacinamide, kojic acid, and alpha-arbutin have strong evidence for reducing periorbital pigmentation. Structural darkness from volume loss responds better to professional fillers than to topical ingredients.
Caffeine has genuine vasoconstricting and anti-edema properties. Topically applied caffeine reaches the dermis via hair follicles within minutes. For vascular-type dark circles, it can temporarily reduce the appearance of visible vessels and puffiness. It is not a standalone cure, but as part of a formulation targeting vascular-type dark circles it contributes meaningfully. Evidence is stronger for short-term visible reduction than long-term structural change.
Both help with the pigmentary type. Niacinamide at 4-5% inhibits melanosome transfer from melanocytes to keratinocytes, reducing visible darkening over time. Vitamin C (L-ascorbic acid) works as both an antioxidant and a tyrosinase inhibitor, with best results when formulated at low pH in a stable form. Neither is as potent as thiamidol or tranexamic acid for severe periorbital pigmentation, but both are well-tolerated for daily use and combine synergistically in multi-ingredient routines.
Shadows are sensitive to overhead directional light, which deepens the appearance of any hollow including the tear trough. Cold weather reduces circulation and can increase visible vascular pooling. Dry, dehydrated skin is more translucent, making underlying vessels more visible. Seasonal UV exposure worsens pigmentary dark circles. All of these effects are real but superficial, meaning they respond to the same interventions that address the underlying cause.
The tear trough is the ligament-anchored groove running from the inner corner of the eye downward along the cheek. As fat pads thin and descend with age, this groove deepens and casts a shadow that reads as a dark circle even when there is no melanin excess or vascular pooling involved. This is a structural cause and responds best to professional treatments (fillers, fat grafting) rather than topical skincare. Topicals that support collagen in the periorbital area may help slow progression over time.
Yes. Genetic factors determine periorbital skin thickness, baseline melanocyte activity, vascular anatomy, and fat distribution in the lower orbital area. People with deeper-set eyes, naturally thinner periorbital skin, or darker Fitzpatrick phototypes tend to show dark circles earlier and more prominently. Genetic dark circles respond more slowly to topical treatment than those caused by lifestyle or accumulated pigment, though consistent use of evidence-backed ingredients still supports visible improvement over time.
The approach depends on the type. For vascular dark circles, a caffeine-based eye product used each morning supports reduced puffiness and visible vessel congestion. For pigmentary dark circles, consistent daily use of tyrosinase inhibitors (niacinamide, alpha-arbutin, or tranexamic acid) over 8 to 12 weeks supports visible improvement. Daily SPF prevents further pigment buildup. Structural darkness from volume loss responds best to professional assessment rather than topical products.
Iron deficiency is the most commonly cited nutritional factor: low iron can reduce oxygen delivery to periorbital tissue, making the underlying vasculature appear more prominent. Vitamin K deficiency has also been linked to impaired blood coagulation, which may worsen vascular-type dark circles. That said, most dark circles are driven by genetics, vascular anatomy, or pigmentation rather than nutritional deficiency. If you suspect a deficiency, a blood panel reviewed by a healthcare professional is the right starting point, not a skincare swap.
Most dark circles are cosmetic and not a cause for medical concern. However, see a dermatologist or doctor if: dark circles appear suddenly with no clear lifestyle explanation, the discoloration changes in shape or texture, you notice swelling that does not resolve, or dark circles are accompanied by other facial or systemic changes. Periorbital darkening can occasionally reflect thyroid dysfunction, kidney issues, or allergic disease. For anything beyond routine cosmetic concern, professional assessment is the right call.
// References
- Ramos-e-Silva M, et al. "Effectiveness and Tolerance of Multicorrective Topical Treatment for Infraorbital Dark Circles and Puffiness." Journal of Cosmetic Dermatology. 2024; doi:10.1111/jocd.16122. pubmed.ncbi.nlm.nih.gov/38112168
- Ranu H, et al. "Infraorbital Dark Circles: Definition, Causes, and Treatment Options." Dermatologic Surgery. 2009; doi:10.1111/j.1524-4725.2009.01241.x. pubmed.ncbi.nlm.nih.gov/19469797
- Sheth N, et al. "Treatments of Periorbital Hyperpigmentation: A Systematic Review." Dermatologic Surgery. 2021; doi:10.1097/DSS.0000000000002484. pubmed.ncbi.nlm.nih.gov/32740208
- Huang L, et al. "Is Diet Related to Skin Condition? A Mendelian Randomization Study." Archives of Dermatological Research. 2024; doi:10.1007/s00403-024-03103-z. pubmed.ncbi.nlm.nih.gov/38824251
- Otberg N, et al. "The Role of Hair Follicles in the Percutaneous Absorption of Caffeine." British Journal of Clinical Pharmacology. 2008; doi:10.1111/j.1365-2125.2007.03065.x. pubmed.ncbi.nlm.nih.gov/18070215
- Hakozaki T, et al. "Effect of a Tranexamic Acid, Kojic Acid, and Niacinamide Containing Serum on Facial Dyschromia: A Clinical Evaluation." Journal of Cosmetic Dermatology. 2019; doi:10.1111/jocd. pubmed.ncbi.nlm.nih.gov/31141852
- Yamazaki H, et al. "The Preventive Effect of Coffee Compounds on Dermatitis and Epidermal Pigmentation After Ultraviolet Irradiation in Mice." Skin Pharmacology and Physiology. 2017; doi:10.1159/000455237. pubmed.ncbi.nlm.nih.gov/28152530
- Hakozaki T, et al. "12-Week, Single-Center Study of a Targeted Pigment-Correcting Dark Spot Treatment for Post-Inflammatory Hyperpigmentation and Solar Lentigines." Clinical, Cosmetic and Investigational Dermatology. 2023. pmc.ncbi.nlm.nih.gov/articles/PMC10544009
- Priya A, et al. "Comparative Study on Depigmenting Agents in Skin of Color." Journal of Clinical and Aesthetic Dermatology. 2022. pmc.ncbi.nlm.nih.gov/articles/PMC8884189
- Hollinger JC, et al. "Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma." Journal of Investigative Dermatology. 2019; doi:10.1016/j.jid.2018.12.032. pubmed.ncbi.nlm.nih.gov/30825454
- Wobser M, et al. "Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol)." International Journal of Cosmetic Science. 2021; doi:10.1111/ics.12669. pubmed.ncbi.nlm.nih.gov/33559186
